Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome

Archives of Ophthalmology

Volumn 118, Issue 9, 2000, Pages 1196-1204

  Holbrook, Janet T ^a   Davis, Matthew D ^c   Hubbard, Larry D ^c   Martin, Barbara K ^a   Holland, Gary N ^d   Jabs, Douglas A ^b   Gilpin, Adele Kaplan ^a   Meinert, Curtis ^a   Reshef, Daniel S ^a  

^a Center for Clincal Trials   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; FOSCARNET SODIUM; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG TOLERABILITY; EARLY DIAGNOSIS; EYE FUNDUS; HUMAN; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINITIS; RISK FACTOR; TREATMENT FAILURE; URINE CULTURE; VIRUS LOAD;

EID: 0033817653     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.118.9.1196     Document Type: Article

References (23)

1. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy
2. Mortality in patients with the acquired immune deficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis
3. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial 4: Visual outcomes
4. Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with ganciclovir or foscarnet
5. Studies of Ocular Complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial, I: Rationale, design and methods
6. Assessment of cytomegalovirus retinitis: Clinical evaluation vs centralized grading of fundus photographs
7. MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with AIDS: The Monoclonal Antibody Cytomegalovirus Retinitis Trial
8. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy: Use of a standardized system for the assessment of disease outcome
9. The validity and reliability of photographic documentation of proliferative vitreoretinopathy
10. Nonparametric estimation from incomplete observations
11. Regression models and life-tables
12. Longitudinal data analysis using generalized linear models
13. The robust inference for the Cox proportional hazards model
14. Cytomegalovirus diseases
15. Progression rates of cytomegalovirus retinopathy in ganciclovir-treated and untreated patients
16. Cytomegalovirus retinitis and viral resistance: 3. Culture results
17. 3
18. + T lymphocyte counts as an adjunctive predictor or cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome
19. T cell subsets and cytomegalovirus retinitis in human immunodeficiency virus-infected patients